The Human I-mfa Domain-Containing Protein, HIC, Interacts with Cyclin T1 and Modulates P-TEFb-Dependent Transcription

REFERENCES

• Barboric, M., R. M. Nissen, S. Kanazawa, N. Jabrane-Ferrat, and B. M. Peterlin. 2001. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8: 327–337.
   PubMed Web of Science ®Google Scholar
• Bourgeois, C. F., Y. K. Kim, M. J. Churcher, M. J. West, and J. Karn. 2002. Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences. Mol. Cell. Biol. 22: 1079–1093.
   PubMed Web of Science ®Google Scholar
• Chen, C. M., N. Kraut, M. Groudine, and H. Weintraub. 1996. I-mf, a novel myogenic repressor, interacts with members of the MyoD family. Cell 86: 731–741.
   PubMed Web of Science ®Google Scholar
• Chun, R. F., O. J. Semmes, C. Neuveut, and K. T. Jeang. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72: 2615–2629.
   PubMed Web of Science ®Google Scholar
• Darbinian, N., B. E. Sawaya, K. Khalili, N. Jaffe, B. Wortman, A. Giordano, and S. Amini. 2001. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells. J. Neuroimmunol. 121: 3–11.
   PubMed Web of Science ®Google Scholar
• Eberhardy, S. R., and P. J. Farnham. 2001. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J. Biol. Chem. 276: 48562–48571.
   PubMed Web of Science ®Google Scholar
• Eberhardy, S. R., and P. J. Farnham. 2002. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277: 40156–40162.
   PubMed Web of Science ®Google Scholar
• Efthymiadis, A., L. J. Briggs, and D. A. Jans. 1998. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. J. Biol. Chem. 273: 1623–1628.
   PubMedGoogle Scholar
• Fong, Y. W., and Q. Zhou. 2000. Relief of two built-in autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 20: 5897–5907.
   PubMed Web of Science ®Google Scholar
• Fujinaga, K., R. Taube, J. Wimmer, T. P. Cujec, and B. M. Peterlin. 1999. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96: 1285–1290.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., T. P. Mayall, E. M. Suess, J. Meisenhelder, N. E. Thompson, and K. A. Jones. 2000. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 20: 6958–6969.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12: 3512–3527.
   PubMed Web of Science ®Google Scholar
• Gold, M. O., X. Yang, C. H. Herrmann, and A. P. Rice. 1998. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo. J. Virol. 72: 4448–4453.
   PubMed Web of Science ®Google Scholar
• Guo, K., and K. Walsh. 1997. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J. Biol. Chem. 272: 791–797.
   PubMedGoogle Scholar
• Herrmann, C. H., and M. A. Mancini. 2001. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J. Cell Sci. 114: 1491–1503.
   PubMed Web of Science ®Google Scholar
• Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69: 1612–1620.
   PubMed Web of Science ®Google Scholar
• Hoque, M., T. M. Young, C. G. Lee, G. Serrero, M. B. Mathews, and T. Pe'ery. 2003. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription. Mol. Cell. Biol. 23: 1688–1702.
   PubMedGoogle Scholar
• Kamine, J., B. Elangovan, T. Subramanian, D. Coleman, and G. Chinnadurai. 1996. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 216: 357–366.
   PubMed Web of Science ®Google Scholar
• Kanazawa, S., T. Okamoto, and B. M. Peterlin. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12: 61–70.
   PubMedGoogle Scholar
• Kiernan, R. E., S. Emiliani, K. Nakayama, A. Castro, J. C. Labbe, T. Lorca, K. Nakayama Ki, and M. Benkirane. 2001. Interaction between cyclin T1 and SCF (SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol. Cell. Biol. 21: 7956–7970.
   PubMedGoogle Scholar
• Kino, T., O. Slobodskaya, G. N. Pavlakis, and G. P. Chrousos. 2002. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J. Biol. Chem. 277: 2396–2405.
   PubMedGoogle Scholar
• Kusano, S., and N. Raab-Traub. 2002. I-mfa domain proteins interact with axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Mol. Cell. Biol. 22: 6303–6405.
   Google Scholar
• Lee, D. K., H. O. Duan, and C. Chang. 2001. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. J. Biol. Chem. 276: 9978–9984.
   PubMed Web of Science ®Google Scholar
• Luznik, L., M. E. Martone, G. Kraus, Y. Zhang, Y. Xu, M. H. Ellisman, and F. Wong-Staal. 1995. Localization of human immunodeficiency virus Rev in transfected and virus-infected cells. AIDS Res. Hum. Retroviruses 11: 795–804.
   PubMedGoogle Scholar
• Majello, B., G. Napolitano, A. Giordano, and L. Lania. 1999. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo. Oncogene 18: 4598–4605.
   PubMed Web of Science ®Google Scholar
• Mancebo, H. S., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11: 2633–2644.
   PubMed Web of Science ®Google Scholar
• Marcello, A., R. A. Cinelli, A. Ferrari, A. Signorelli, M. Tyagi, V. Pellegrini, F. Beltram, and M. Giacca. 2001. Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer. J. Biol. Chem. 276: 39220–39225.
   PubMedGoogle Scholar
• Marcello, A., A. Ferrari, V. Pellegrini, G. Pegoraro, M. Lusic, F. Beltram, and M. Giacca. 2003. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J. 22: 2156–2166.
   PubMed Web of Science ®Google Scholar
• Marshall, N. F., and D. H. Price. 1995. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270: 12335–12338.
   PubMed Web of Science ®Google Scholar
• Michienzi, A., S. Li, J. A. Zaia, and J. J. Rossi. 2002. A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc. Natl. Acad. Sci. USA 99: 14047–14052.
   PubMed Web of Science ®Google Scholar
• Mizutani, T., K. Yamada, T. Yazawa, T. Okada, T. Minegishi, and K. Miyamoto. 2001. Cloning and characterization of gonadotropin-inducible ovarian transcription factors (GIOT1 and -2) that are novel members of the (Cys)(2)-(His)(2)-type zinc finger protein family. Mol. Endocrinol. 15: 1693–1705.
   PubMed Web of Science ®Google Scholar
• Morris, G. F., and M. B. Mathews. 1990. Analysis of the proliferating cell nuclear antigen promoter and its response to adenovirus early region 1. J. Biol. Chem. 265: 16116–16125.
   PubMedGoogle Scholar
• Napolitano, G., P. Licciardo, R. Carbone, B. Majello, and L. Lania. 2002. CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization. J. Cell Physiol. 192: 209–215.
   PubMedGoogle Scholar
• Nguyen, V. T., T. Kiss, A. A. Michels, and O. Bensaude. 2001. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414: 322–325.
   PubMed Web of Science ®Google Scholar
• Pendergrast, P. S., C. Wang, N. Hernandez, and S. Huang. 2002. FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles. Mol. Biol. Cell 13: 915–929.
   PubMed Web of Science ®Google Scholar
• Peng, J., N. F. Marshall, and D. H. Price. 1998. Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J. Biol. Chem. 273: 13855–13860.
   PubMed Web of Science ®Google Scholar
• Peng, J., Y. Zhu, J. T. Milton, and D. H. Price. 1998. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12: 755–762.
   PubMed Web of Science ®Google Scholar
• Price, D. H. 2000. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20: 2629–2634.
   PubMed Web of Science ®Google Scholar
• Ramanathan, Y., S. M. Reza, T. M. Young, M. B. Mathews, and T. Pe'ery. 1999. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 Tat and carboxy-terminal domain substrate. J. Virol. 73: 5448–5458.
   PubMed Web of Science ®Google Scholar
• Reza, S. M., M. Rosetti, M. B. Mathews, and T. Pe'ery. 2003. Differential activation of Tat variants in mitogen-stimulated cells: implications for HIV-1 postintegration latency. Virology 310: 141–156.
   PubMedGoogle Scholar
• Sano, M., M. Abdellatif, H. Oh, M. Xie, L. Bagella, A. Giordano, L. H. Michael, F. J. DeMayo, and M. D. Schneider. 2002. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat. Med. 8: 1310–1317.
   PubMed Web of Science ®Google Scholar
• Simone, C., P. Stiegler, L. Bagella, B. Pucci, C. Bellan, G. De Falco, A. De Luca, G. Guanti, P. L. Puri, and A. Giordano. 2002. Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene 21: 4137–4148.
   PubMed Web of Science ®Google Scholar
• Skapek, S. X., J. Rhee, P. S. Kim, B. G. Novitch, and A. B. Lassar. 1996. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol. 16: 7043–7053.
   PubMedGoogle Scholar
• Snider, L., H. Thirlwell, J. R. Miller, R. T. Moon, M. Groudine, and S. J. Tapscott. 2001. Inhibition of Tcf3 binding by I-mfa domain proteins. Mol. Cell. Biol. 21: 1866–1873.
   PubMedGoogle Scholar
• Taube, R., X. Lin, D. Irwin, K. Fujinaga, and B. M. Peterlin. 2002. Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol. Cell. Biol. 22: 321–331.
   PubMed Web of Science ®Google Scholar
• Thébault, S., F. Gachon, I. Lemasson, C. Devaux, and J. M. Mesnard. 2000. Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type I and HIV-1 expression. J. Biol. Chem. 275: 4848–4857.
   PubMed Web of Science ®Google Scholar
• Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92: 451–462.
   PubMed Web of Science ®Google Scholar
• Weissman, J. D., J. R. Hwang, and D. S. Singer. 2001. Extensive interactions between HIV TAT and TAF(II)250. Biochim. Biophys. Acta 1546: 156–163.
   PubMed Web of Science ®Google Scholar
• Yang, X., M. O. Gold, D. N. Tang, D. E. Lewis, E. Aguilar-Cordova, A. P. Rice, and C. H. Herrmann. 1997. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA 94: 12331–12336.
   PubMed Web of Science ®Google Scholar
• Yang, Z., Q. Zhu, K. Luo, and Q. Zhou. 2001. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414: 317–322.
   PubMed Web of Science ®Google Scholar
• Zhang, F., M. Barboric, T. K. Blackwell, and B. M. Peterlin. 2003. A model of repression: CTD analogs and PIE-1 inhibit transcriptional elongation by P-TEFb. Genes Dev. 17: 748–758.
   PubMedGoogle Scholar
• Zhang, J. M., Q. Wei, X. Zhao, and B. M. Paterson. 1999. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J. 18: 926–933.
   PubMedGoogle Scholar
• Zhang, J. M., X. Zhao, Q. Wei, and B. M. Paterson. 1999. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J. 18: 6983–6993.
   PubMedGoogle Scholar
• Zhou, Q., and P. A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14: 321–328.
   PubMedGoogle Scholar
• Zhou, Q., and P. A. Sharp. 1996. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274: 605–610.
   PubMedGoogle Scholar
• Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11: 2622–2632.
   PubMed Web of Science ®Google Scholar